The relationship between alloimmunization and posttransfusion granulocyte survival: Experience in a chronic granulomatous disease cohort

Transfusion

Volumn 51, Issue 6, 2011, Pages 1154-1162

  Heim, K F ^a,b   Fleisher, T A ^a,b   Stroncek, D F ^a,b   Holland, S M ^a,b   Gallin, J I ^a,b   Malech, H L ^a,b   Leitman, S F ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DIHYDRORHODAMINE 123; GRANULOCYTE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIBODY; HLA ANTIGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID;

ADOLESCENT; ADULT; ALLERGY; ALLOIMMUNIZATION; ANTIBODY DETECTION; APHERESIS; ARTICLE; BACTERIAL PNEUMONIA; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CELL MIGRATION; CELL SURVIVAL; CHILD; CHILL; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CYANOSIS; DRUG WITHDRAWAL; DYSPNEA; ENZYME ACTIVITY; FEMALE; FEVER; FLANK PAIN; GRANULOCYTE TRANSFUSION; HLA SYSTEM; HUMAN; IN VIVO STUDY; LIVER ABSCESS; LUNG MYCOSIS; MALE; NEUTROPHIL; NEUTROPHIL COUNT; NOCARDIOSIS; OXYGEN SATURATION; PRESCHOOL CHILD; PULMONARY REACTION; RESPIRATORY FAILURE; RIGOR; SCHOOL CHILD; SIDE EFFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LEUKOCYTE TRANSFUSION; MALE; NEUTROPHILS; YOUNG ADULT;

EID: 79958806095     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02993.x     Document Type: Article

References (30)

1. Clark RA, Malech HL, Gallin JI, Nunoi H, Volpp BD, Pearson DW, Nauseef WM, Curnutte JT,. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med 1989; 321: 647-52. (Pubitemid 19221309)
2. Gallin JI, Malech HL,. Update on chronic granulomatous diseases of childhood: immunotherapy and potential for gene therapy. JAMA 1990; 263: 1533-7. (Pubitemid 20099050)
3. Smith RM, Curnutte JT,. Molecular basis of chronic granulomatous disease. Blood 1991; 77: 673-86.
4. Volpp BD, Nauseef WM, Clark RA,. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 1988; 242: 1295-7. (Pubitemid 19008058)
5. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991; 324: 509-16.
6. Strauss RG,. Granulocyte transfusion therapy. Hematol Oncol Clin North Am 1994; 8: 1159-66. (Pubitemid 24364165)
7. Strauss RG,. Granulocyte transfusions. In:, Rossi EC, Simon TL, Moss GS, Gould SA, editors. Principles of transfusion medicine. Baltimore: Williams & Wilkins; 1996. p. 321-8.
8. DePalma L, Leitman SF, Carter CS, Gallin JI,. Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple red cell alloantibodies. Transfusion 1989; 29: 421-3. (Pubitemid 19196229)
9. Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S, Vowells SJ, Li F, Miller JA, DeCarlo E, Holland SM, Leitman SF, Carter CS, Butz RE, Read EJ, Fleisher TA, Schneiderman R, Van Epps D, Spratt SK, Maack CA, Rokovich JA, Cohen LK, Gallin JI,. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A 1997; 94: 12133-8. (Pubitemid 27467855)
10. Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, Holland SM, Linton GF, Miller JA, Leitman SF, Read EJ, Malech HL,. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001; 344: 881-8. (Pubitemid 32224396)
11. Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF,. Alloimmunization after granulocyte transfusions. Transfusion 1996; 36: 1009-15. (Pubitemid 26394149)
12. McCullough J, Clay M, Hurd D, Richards K, Ludvigsen C, Forstrom L,. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood 1986; 67: 522-8. (Pubitemid 16164675)
13. Dutcher JP, Riggs C Jr, Fox JJ, Johnston GS, Norris D, Wiernik PH, Schiffer CA,. Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes. Am J Hematol 1990; 33: 238-43. (Pubitemid 20116290)
14. Stroncek DF, Shapiro RS, Filipovich AH, Plachta LB, Clay ME,. Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation. Transfusion 1993; 33: 158-63. (Pubitemid 23060550)
15. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB,. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981; 304: 1185-9. (Pubitemid 11102796)
16. Karp DD, Ervin TJ, Tuttle S, Gorgone BC, Lavin P, Yunis EJ,. Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang 1982; 42: 57-61. (Pubitemid 12168615)
17. Herzig R,. The negative aspects of granulocyte transfusions. Cancer Invest 1989; 7: 589-92. (Pubitemid 20161624)
18. Rothe G, Oser A, Valet G,. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 1988; 75: 354-5.
19. Rothe G, Emmendörffer A, Oser A, Roesler J, Valet G,. Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123. J Immunol Methods 1991; 138: 133-5.
20. Rothe G, Valet G,. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol 1994; 233: 539-48.
21. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA,. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995; 178: 89-97.
22. Leitman SF, Oblitas JM,. Optimization of granulocytapheresis mobilization regimens using granulocyte colony-stimulating factor and dexamethasone. Transfusion 1997; 37: 268s.
23. Adkins D, Spitzer G, Johnston M, Velasquez W, Dunphy F, Petruska P,. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte compounds to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997; 37: 737-48. (Pubitemid 27297615)
24. Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC,. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997; 37: 182-7. (Pubitemid 27091904)
25. Stroncek DF, Yau YY, Oblitas J, Leitman SF,. Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone. Transfusion 2001; 41: 1037-44. (Pubitemid 33642794)
26. Terasaki PI, Park MS,. Microdroplet lymphocyte cytotoxicity test. In:, Ray JG, Hare DB, Pederson PD, Mullally DI, editors. NIAID manual of tissue typing techniques. Bethesda: DHEW (Publication no. [NIH] 77-545); 1976. p. 69.
27. 111Indium-labeled granulocytes to sites of infection. N Engl J Med 1981; 304: 586-9. (Pubitemid 11142466)
28. Vamvakas EC, Pineda AA,. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apheresis 1997; 12: 74-81. (Pubitemid 27332727)
29. Quillen K, Wong E, Scheinberg P, Young NS, Walsh TJ, Wu CO, Leitman SF,. Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica 2009; 94: 1661-8.
30. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC,. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000; 95: 3302-9. (Pubitemid 30428457)